Zura Bio Ltd. (ZURA)
4.04
-0.12
(-2.88%)
USD |
NASDAQ |
Sep 25, 16:00
4.045
0.00 (0.00%)
After-Hours: 19:59
Zura Bio EPS Diluted (Quarterly) : -0.2074 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.2074 |
| March 31, 2026 | -0.2159 |
| December 31, 2025 | -0.6227 |
| September 30, 2025 | -0.2119 |
| June 30, 2025 | -0.1696 |
| March 31, 2025 | -0.1876 |
| December 31, 2024 | -0.1386 |
| September 30, 2024 | -0.2627 |
| June 30, 2024 | -0.169 |
| March 31, 2024 | -0.0156 |
| December 31, 2023 | -0.144 |
| Date | Value |
|---|---|
| September 30, 2023 | -0.1764 |
| June 30, 2023 | -1.309 |
| March 31, 2023 | -2.758 |
| December 31, 2022 | 0.7765 |
| September 30, 2022 | -2.874 |
| June 30, 2022 | -9.536 |
| March 31, 2022 | -72398.15 |
| December 31, 2021 | 0.0474 |
| September 30, 2021 | 0.3355 |
| June 30, 2021 | -0.0011 |
| March 31, 2021 | -0.0019 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| NovelStem International Corp. | -0.0017 |
| Brainstorm Cell Therapeutics, Inc. | -0.3494 |
| Summit Therapeutics, Inc. | -0.2772 |
| Kezar Life Sciences, Inc. | -0.7838 |
| Protara Therapeutics, Inc. | -0.3552 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -26.30M |
| Total Expenses (Quarterly) | 26.30M |
| Enterprise Value | 180.37M |
| Earnings Yield | -31.14% |
| Normalized Earnings Yield | -31.14 |